Skip to main content

MoneyWorks4Me

A fair growth of 10.53% in the revenue at Rs. 455.58 millions was reported in the September 2025 quarter as compared to Rs. 412.16 millions during year-ago period.A humble growth in net profit of 5.84% reported in the quarter ended September 2025 to Rs. 101.63  millions from Rs. 96.02 millions.Operating profit surged to 151.83 millions from the corresponding previous quarter of 132.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 455.58 412.16 10.53 810.85 737.52 9.94 1516.92 1419.66 6.85
Other Income 20.79 18.53 12.20 41.36 32.59 26.91 67.21 46.67 44.01
PBIDT 151.83 132.79 14.34 261.98 239.73 9.28 471.13 377.85 24.69
Interest 1.07 1.16 -7.76 2.17 2.31 -6.06 4.53 2.71 67.16
PBDT 150.76 131.63 14.53 259.81 237.42 9.43 466.60 375.14 24.38
Depreciation 7.44 6.39 16.43 14.66 11.58 26.60 27.28 23.40 16.58
PBT 143.32 125.24 14.44 245.15 225.84 8.55 439.32 351.74 24.90
TAX 41.69 29.22 42.68 65.59 55.67 17.82 118.72 91.98 29.07
Deferred Tax 1.69 -0.78 -316.67 5.59 0.67 734.33 -2.06 -5.21 -60.46
PAT 101.63 96.02 5.84 179.56 170.17 5.52 320.60 259.76 23.42
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 33.33 32.22 3.44 32.31 32.50 -0.60 31.06 26.62 16.69
Peers
Company Name CMP
Sun Pharma. Inds. 1904.50
Dr. Reddys Labs. 1376.45
Cipla 1412.75
Lupin 1998.05
Zydus Lifesciences 1204.15
View more..